Gabawin-ER 165 Tablet contains Pregabalin 165mg, an anticonvulsant and neuropathic pain agent used primarily to manage conditions such as epilepsy, neuropathic pain, fibromyalgia, and generalized anxiety disorder. Pregabalin works by binding to the alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system, which reduces the release of several neurotransmitters involved in pain and seizure activity. Gabawin-ER 165 is an extended-release formulation designed to provide a consistent therapeutic effect over an extended period, improving patient compliance by reducing dosing frequency. It is commonly prescribed to control partial-onset seizures in adults and to alleviate nerve pain associated with diabetic peripheral neuropathy, postherpetic neuralgia, and spinal cord injury. Additionally, it helps in managing fibromyalgia symptoms and generalized anxiety disorder. Patients should take Gabawin-ER 165 exactly as prescribed, usually once daily, with or without food. Common side effects may include dizziness, somnolence, dry mouth, edema, blurred vision, and weight gain. It is important to avoid abrupt discontinuation to prevent withdrawal symptoms. Gabawin-ER 165 should be used cautiously in patients with renal impairment and those with a history of substance abuse. Always consult a healthcare professional before starting or stopping this medication.